Compile Data Set for Download or QSAR
Report error Found 210 Enz. Inhib. hit(s) with all data for entry = 50030848
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302692((S)-4-(6-(4-(azetidine-1-carbonyl)piperidin-1-yl)-...)
Affinity DataIC50: 230nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302690((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 270nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302695((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50: 280nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302698((S)-4-(6-(4-(dimethylcarbamoyl)piperidin-1-yl)-2-p...)
Affinity DataIC50: 370nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302691((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 390nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302694((S)-4-(6-(4-(diethylcarbamoyl)piperidin-1-yl)-2-ph...)
Affinity DataIC50: 400nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302719((S)-4-(6-(4-(2-(dimethylamino)ethyl)piperidin-1-yl...)
Affinity DataIC50: 400nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302697((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(4-(4-(...)
Affinity DataIC50: 490nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302729((S)-4-(6-(4-(aminomethyl)piperidin-1-yl)-2-phenylp...)
Affinity DataIC50: 490nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302629((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 510nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302636((S)-4-(6-(4-(2-(dimethylamino)-2-oxoethyl)piperazi...)
Affinity DataIC50: 530nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302722((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 560nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302721((S)-4-(6-(4-(2-aminoethyl)piperidin-1-yl)-2-phenyl...)
Affinity DataIC50: 620nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302630((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 660nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302701((S)-4-(6-(4-carbamoylpiperidin-1-yl)-2-phenylpyrim...)
Affinity DataIC50: 690nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302646((S)-4-(6-(4-aminopiperidin-1-yl)-2-phenylpyrimidin...)
Affinity DataIC50: 720nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302727((S)-4-(6-(4-((methylamino)methyl)piperidin-1-yl)-2...)
Affinity DataIC50: 740nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302725((S)-4-(6-(4-((ethylamino)methyl)piperidin-1-yl)-2-...)
Affinity DataIC50: 770nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302728((S)-4-(4-(4-(aminomethyl)piperidin-1-yl)-6-phenylp...)
Affinity DataIC50: 770nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302626((S)-4-(6-(4-morpholinopiperidin-1-yl)-2-phenylpyri...)
Affinity DataIC50: 780nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302718((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 810nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302723((4S)-4-[(6-{4-[(diethylamino)methyl]piperidin-1-yl...)
Affinity DataIC50: 860nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302627((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataIC50: 880nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302696((S)-4-(6-(4-(ethylcarbamoyl)piperidin-1-yl)-2-phen...)
Affinity DataIC50: 930nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302640((S)-4-(6-(4-carbamoylpiperazin-1-yl)-2-phenylpyrim...)
Affinity DataIC50: 940nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302685((S)-4-(6-(4-(2-(azetidin-1-yl)-2-oxoethyl)piperidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302634((S)-5-oxo-4-(6-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)...)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302688((S)-4-(6-(4-(2-(methylamino)-2-oxoethyl)piperidin-...)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302667((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302705((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302724((S)-4-(4-(4-((ethylamino)methyl)piperidin-1-yl)-6-...)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302644((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302669((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302693((S)-4-(4-(4-(diethylcarbamoyl)piperidin-1-yl)-6-ph...)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302711((S)-4-(6-(4-(2-hydroxyethoxy)piperidin-1-yl)-2-phe...)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302726((S)-4-(4-(4-((methylamino)methyl)piperidin-1-yl)-6...)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302648((S)-4-(6-(4-methylpiperazin-1-yl)-2-phenylpyrimidi...)
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302713((S)-4-(6-(4-(2-methoxyethoxy)piperidin-1-yl)-2-phe...)
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302720((S)-4-(4-(4-(2-aminoethyl)piperidin-1-yl)-6-phenyl...)
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302642((S)-4-(6-(4-acetylpiperazin-1-yl)-2-phenylpyrimidi...)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302684((S)-5-oxo-4-(6-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)...)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302689((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302699((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302638((S)-4-(6-(4-(dimethylcarbamoyl)piperazin-1-yl)-2-p...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302687((S)-4-(6-(4-(2-(ethylamino)-2-oxoethyl)piperidin-1...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302702((S)-5-oxo-4-(6-(4-((2-oxopyrrolidin-1-yl)methyl)pi...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302666((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 1.70E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302717((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 1.70E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302668((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(1-i...)
Affinity DataIC50: 1.80E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302716((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataIC50: 1.80E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 210 total ) | Next | Last >>
Jump to: